New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aprea Therapeutics, Inc.
APRE
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

19M

Biotechnology

Next Earning date - 25 Mar 2025

19M

Biotechnology

Next Earning date - 25 Mar 2025

3.59USD

Shape0.06 ( 1.58%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

23
favorite-chart

Volume Buzz

-73%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

59%

Quote Panel

Shape
Updated February 17, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

APRE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$900K

ShapeNaN%

2025-Revenue

$1.46

Shape-129%

2025-EPS

$540K

Shape113%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Loop Capital Markets

initialise

Previous: Not converted

2023-03-10

Now: Buy

Citigroup

initialise

Previous: Not converted

2023-03-10

Now: Buy

RBC Capital

initialise

Previous: Not converted

2023-03-10

Now: Outperform

Cowen & Co.

initialise

Previous: Not converted

2023-03-10

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.92
vs -7.20

Q1.23

arrow
arrow

N/A

NA
vs -7.20

Q2.23

arrow
arrow

N/A

-0.87
vs -19.80

Q3.23

arrow
arrow

N/A

-0.86
vs -2.40

Q4.23

arrow
arrow

N/A

-0.92
vs -0.92

Q1.24

arrow
arrow

N/A

-0.67
vs NA

Q2.24

arrow
arrow

N/A

-0.58
vs -0.87

Q3.24

arrow
arrow

N/A

-0.64
vs -0.86

Q4.24

arrow
arrow

N/A

-0.66
vs -0.92

Q1.25

arrow
arrow

N/A

-0.69
vs -0.67

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

249.7K  vs NA

Q3.23

arrow
arrow

NA

319.5K  vs NA

Q4.23

arrow
arrow

NA

14.1K  vs NA

Q1.24

arrow
arrow

NA

380.6K  vs NA

Q2.24

arrow
arrow

+125%

561.6K  vs 249.7K

Q3.24

arrow
arrow

-100%

NA  vs 319.5K

Q4.24

arrow
arrow

+1499%

225K  vs 14.1K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-432%

-4.32
vs -0.16

Q1.23

arrow
arrow

-16%

-0.16
vs -4.32

Q2.23

arrow
arrow

-14%

-0.14
vs -0.16

Q3.23

arrow
arrow

-16%

-0.16
vs -0.14

Q4.23

arrow
arrow

-19%

-0.19
vs -0.16

Q1.24

arrow
arrow

-9%

-0.09
vs -0.19

Q2.24

arrow
arrow

-13%

-0.13
vs -0.09

Q3.24

arrow
arrow

-17%

-0.17
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

27

27
vs 25

8%

Q1.23

arrow
arrow

2

2
vs 27

-93%

Q2.23

arrow
arrow

1

1
vs 2

-50%

Q3.23

arrow
arrow

1

1
vs 1

NA

Q4.23

arrow
arrow

1

1
vs 1

NA

Q1.24

arrow
arrow

2

2
vs 1

100%

Q2.24

arrow
arrow

1

1
vs 2

-50%

Q3.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News